After menopause, circulating estrogens, which derive from adipose tissue (AT), are associated with an increase of both risk and progression of estrogen receptor positive (ER+) breast cancer [5] because estrogens are well known to be involved in breast cancer progression. This evidence concerns the gene ESR1 and breast cancer.